Juvenile Idiopathic Arthritis

Rituximab May Benefit Patients with Refractory JIA-Associated Uveitis

NEW YORK (Reuters Health)—Rituximab may calm juvenile idiopathic arthritis (JIA)-associated uveitis and especially benefit patients who haven’t responded to…
Adalimumab effective for Uveitis in Juvenile Idiopathic Arthritis patients

Drug Effective for JIA-Associated Eye Disease

A UK team reporting at the American College of Rheumatology Annual Meeting in San Francisco, CA said it found that adalimumab (Humira/AbbVie)…